Evidence map›Paper›PMID 38382526›Full record

ArticleMolecular cell2024

Cullin-RING ligases employ geometrically optimized catalytic partners for substrate targeting.

Jerry Li, Nicholas Purser, Joanna Liwocha, Daniel C Scott, Holly A Byers, Barbara Steigenberger, Spencer Hill, Ishita Tripathi-Giesgen, Trent Hinkle, Fynn M Hansen and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. E2 variants for probing E3 ubiquitin ligase activities.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. A Kinetic Scout Approach Accelerates Targeted Protein Degrader Development.Angewandte Chemie (International ed. in English) · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Jerry LiDepartment of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, NV 89154, USA.
Nicholas PurserDepartment of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, NV 89154, USA.
Joanna LiwochaDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
Daniel C ScottDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Holly A ByersDepartment of Pathology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Barbara SteigenbergerMass Spectrometry Core Facility, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
Spencer HillDepartment of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, NV 89154, USA.
Ishita Tripathi-GiesgenDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
Trent HinkleGenentech, 1 DNA Way, South San Francisco, CA 94080, USA.
Fynn M HansenDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
J Rajan PrabuDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
Senthil K RadhakrishnanDepartment of Pathology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Donald S KirkpatrickGenentech, 1 DNA Way, South San Francisco, CA 94080, USA.
Kurt M ReichermeierGenentech, 1 DNA Way, South San Francisco, CA 94080, USA.
Brenda A SchulmanDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried 82152, Germany; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: schulman@biochem.mpg.de.
Gary KleigerDepartment of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, NV 89154, USA; Department of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried 82152, Germany. Electronic address: gary.kleiger@unlv.edu.
Max Planck Institute of Biochemistry · DEUniversity of Nevada, Las Vegas · USVirginia Commonwealth University · USSt. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Plasticity and Function of Dopamine Circuits Regulating the Transition to HabitR01MH125885 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Jones G Parker · 2023 to 2026
$2.0M
Nrf1-dependent Proteotoxic Stress Response - Diversity SupplementR01GM132396 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI RADHAKRISHNAN, SENTHIL KUMAR · 2019 to 2023
$1.9M
How ubiquitin-carrying enzymes contribute to ubiquitin ligase specificityR01GM141409 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI KLEIGER, GARY L. · 2021 to 2024
$1.6M
NCI NIH HHS P30 CA021765NIGMS NIH HHS R01 GM132396NIGMS NIH HHS R01 GM141409NIMH NIH HHS R01 MH125885
6 · The paper itself

Abstract

Cullin-RING ligases (CRLs) ubiquitylate specific substrates selected from other cellular proteins. Substrate discrimination and ubiquitin transferase activity were thought to be strictly separated. Substrates are recognized by substrate receptors, such as Fbox or BCbox proteins. Meanwhile, CRLs employ assorted ubiquitin-carrying enzymes (UCEs, which are a collection of E2 and ARIH-family E3s) specialized for either initial substrate ubiquitylation (priming) or forging poly-ubiquitin chains. We discovered specific human CRL-UCE pairings governing substrate priming. The results reveal pairing of CUL2-based CRLs and UBE2R-family UCEs in cells, essential for efficient PROTAC-induced neo-substrate degradation. Despite UBE2R2's intrinsic programming to catalyze poly-ubiquitylation, CUL2 employs this UCE for geometrically precise PROTAC-dependent ubiquitylation of a neo-substrate and for rapid priming of substrates recruited to diverse receptors. Cryo-EM structures illuminate how CUL2-based CRLs engage UBE2R2 to activate substrate ubiquitylation. Thus, pairing with a specific UCE overcomes E2 catalytic limitations to drive substrate ubiquitylation and targeted protein degradation.

Indexed as

Cullin ProteinsUbiquitin-Protein LigasesCarrier ProteinsHumansPolyubiquitinUbiquitinUbiquitinationCarrier ProteinsCullin ProteinsPolyubiquitinUbiquitinUbiquitin-Protein Ligasescryo-EME2E3PROTACproteolysis targeting chimeratargeted protein degradationubiquitinubiquitin-carrying enzymeubiquitin-conjugating enzymeubiquitin ligase

Identifiers

PMID38382526
PMCPMC10997478
OpenAlexW4391987176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.